Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
102.4 EUR
1.99%
Updated:
Apr 30, 2024
Gerresheimer AG
Cash from Financing Activities
|
Gerresheimer AG
Cash from Financing Activities Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Cash from Financing Activities
-€3.6m
|
CAGR 3-Years
64%
|
CAGR 5-Years
39%
|
CAGR 10-Years
17%
|
|
E
|
Evotec SE
XETRA:EVT
|
Cash from Financing Activities
€51.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Cash from Financing Activities
-€11.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Cash from Financing Activities?
Cash from Financing Activities
-3.6m
EUR
-3.6m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Cash from Financing Activities amounts to -3.6m EUR.
What is Gerresheimer AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
17%
17%
The average annual Cash from Financing Activities growth rates for Gerresheimer AG have been 64% over the past three years , 39% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
